Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Obesity Diabetes and impaired glucose tolerance Drug choice in pregnancy ECG changes - QT prolongation Effects of antipsychotic medications on plasma lipids Psychosis in children and adolescents Treatment of antipsychotic-induced weight gain
Object relations
Obsessive compulsive disorder Obsessive compulsive disorder (OCD) and body dysmorphic disorder (BDD) in children and adolescents with autism spectrum disorder
obsessive compulsive disorder (OCD)
obstetric and gynaecological haemorrhage, SSRI risks
Ocular effects, antipsychotics
Oesophageal varices, consequences of reduced hepatic blood flow
Oestrogen antipsychotic effects decline in menopausal women selective oestrogen receptor modulators
Oestrogen augmentation
Oestrogen interactions
Olanzapine/fluoxetine combination, children and adolescents with bipolar depression
Olanzapine/samidorphan combination, bipolar disorder
Olanzapine pamoate Equivalent doses Quick reference for licensed maximum doses
Olanzapine
Older people alzheimerâ™s disease behavioural and psychological symptoms of dementia management covert administration of medicines in food and drink dose recommendations for common psychotropics drugs general prescribing principles inappropriate sexual behaviour
Omega-3 (polyunsaturated) fatty acids (fish oils or supplements) borderline personality disorder dyslipidaemia treatment mild/moderate depression in older adults schizophrenia treatment and prevention tardive dyskinesia
Ondansetron Alternatives to clozapine Treatment of tardive dyskinesia
Onset of action
Opioid antagonists, borderline personality disorder
Opioid dependence changes in prescribing practice Opioid dependence opioid receptor agonists, buprenorphine versus methadone or opioids overdose prescribing psychotropic medications timecourse of withdrawal symptoms
Opioids detoxification and reduction regimens diversion potential of misused substances driving impairment misuse overdose risk after detoxification overdose symptoms and treatment psychiatric adverse effects relapse prevention with naltrexone safe storage importance safety in older patients/dementia transferring from prescription drugs to buprenorphine
opioid substitution treatment (OST) 500-519 alternative oral preparations induction and stabilisation of maintenance treatment pain control in patients paliperidone diamorphine relapse prevention with naltrexone safe prescribing slow-release oral morphine
Opioid withdrawal buprenorphine community settings methadone specialist addiction in-patient settings timecourse of symptoms treatment of symptoms validated scales
Optimal dosage
Optimising lithium treatment for prophylaxis in bipolar disorder
Options for menopausal women
oral glucose tolerance tests (OGTT) 176
Orlistat for antipsychotic-induced weight gain for constipation treatment
orodispersible drug administration, Espranor/buprenorphine
Orthostatic hypotension Blood pressure changes with antipsychotics Switching antipsychotics